Tyndall Capital Partners L P, 10% Owner at Onconova Therapeutics, Inc. (ONTX), bought 1,100,000 shares at $1.01 ($1.1M) on 2018-02-08, disclosed to the SEC on 2018-02-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ONTX | SELL | 2019-09-20 | $210K | — | Filing → |
| ONTX | SELL | 2019-09-13 | $3K | — | Filing → |
| ONTX | SELL | 2019-09-11 | $1K | — | Filing → |